Newrotex
PrivateLast Round
Grant
Jan 1, 2024
Total Funding Raised
$6.03M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Newrotex is a surgical devices company that develops silk-based medical solutions for peripheral nerve repair.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Newrotex Comparables
Compare Newrotex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReNerve Limited | 83% | |
| Axonova Medical | 81% | |
| Auxilium Biotechnologies | 78% |
Newrotex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2024 | ||||
| Accelerator | Oct 11, 2023 | ||||
| Grant | Mar 22, 2023 | ||||
| Grant | Aug 1, 2022 | ||||
| Grant | May 1, 2020 | ||||
Grant | May 1, 2020 |
Key People
Founding team and executive leadership
Newrotex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Horizon Europe Guarantee | Grant |
| MedTech Innovator | Accelerator |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 100% MoM, reaching 3.1K.
- Apr 17, 2026
Monthly visitors grew 210% MoM, reaching 1.7K.
Newrotex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Newrotex's valuation, stock price, and market status.
Is Newrotex a public or private company?
Newrotex is a private company.
What is the current stock price of Newrotex?
Newrotex is a private company with no public stock price. No recent secondary market data is available.
How much is Newrotex worth (valuation)?
Valuation information for Newrotex is not publicly available.
Can I buy Newrotex stock?
Newrotex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Newrotex's last funding round?
Newrotex's most recent funding round was Grant on January 1, 2024.
Who are the main investors in Newrotex?
Key investors in Newrotex include European Innovation Council, Horizon Europe Guarantee, Innovate UK.
Will Newrotex IPO soon?
No public IPO plans have been announced for Newrotex.
How can I track Newrotex secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Newrotex's secondary market activity and sign up for updates.